Presentation is loading. Please wait.

Presentation is loading. Please wait.

Phillip S. Naimo, MD, David McGiffin, MD, FRACS, Igor E

Similar presentations


Presentation on theme: "Phillip S. Naimo, MD, David McGiffin, MD, FRACS, Igor E"— Presentation transcript:

1 Aspirin resistance in the era of personalized medicine: Should we not take it personally? 
Phillip S. Naimo, MD, David McGiffin, MD, FRACS, Igor E. Konstantinov, MD, PhD, FRACS  The Journal of Thoracic and Cardiovascular Surgery  Volume 150, Issue 6, Pages e99-e100 (December 2015) DOI: /j.jtcvs Copyright © Terms and Conditions

2 Figure 1 Schematic impact of low-dose aspirin on platelet activation and aggregation. Aspirin in low doses may leave some COX-2, production of which may significantly increase in inflammatory conditions, uninhibited, and result in increased platelet activation and aggregation. COX, Cyclooxygenase. The Journal of Thoracic and Cardiovascular Surgery  , e99-e100DOI: ( /j.jtcvs ) Copyright © Terms and Conditions

3 Schematic of aspirin impact on platelets.
The Journal of Thoracic and Cardiovascular Surgery  , e99-e100DOI: ( /j.jtcvs ) Copyright © Terms and Conditions


Download ppt "Phillip S. Naimo, MD, David McGiffin, MD, FRACS, Igor E"

Similar presentations


Ads by Google